lutetium has been researched along with zirconium in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Leemans, CR; Perk, LR; Stigter-van Walsum, M; Tijink, BM; van Dongen, GA; Visser, GW; Vosjan, MJ | 1 |
Adam, MJ; Lewis, JS; Orvig, C; Price, EW; Zeglis, BM | 1 |
Balogh, L; Bóta, A; Dabasi, G; Drotár, E; Jóba, RP; Mikolajczak, R; Nagy, LN; Polyak, A; Pöstényi, Z | 1 |
Adumeau, P; Davydova, M; Zeglis, BM | 1 |
Erdemir, RU; Issa, SAM; Mostafa, MYA; Tekin, HO; Zakaly, HMH; Zhukovsky, M | 1 |
5 other study(ies) available for lutetium and zirconium
Article | Year |
---|---|
(89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Delivery Systems; Female; Humans; Lutetium; Metabolic Clearance Rate; Mice; Mice, Nude; Organ Specificity; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Yttrium Radioisotopes; Zirconium | 2005 |
H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177Lu.
Topics: Animals; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Chelating Agents; Female; Humans; Indium; Isotope Labeling; Lutetium; Mice; Mice, Nude; Organophosphorus Compounds; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Radioisotopes; Trastuzumab; Zirconium | 2014 |
Lu-177-Labeled Zirconia Particles for Radiation Synovectomy.
Topics: Animals; Colloids; Dog Diseases; Dogs; Lutetium; Osteoarthritis; Radioisotopes; Synovial Membrane; Tarsal Joints; Tomography, Emission-Computed, Single-Photon; Zirconium | 2015 |
Thiol-Reactive Bifunctional Chelators for the Creation of Site-Selectively Modified Radioimmunoconjugates with Improved Stability.
Topics: Animals; Chelating Agents; Humans; Immunoconjugates; Lutetium; Mesylates; Mice; Mice, Nude; Neoplasms; Positron-Emission Tomography; Radioisotopes; Sulfhydryl Compounds; Zirconium | 2018 |
Assessment of absorbed dose for Zr-89, Sm-153 and Lu-177 medical radioisotopes: IDAC-Dose2.1 and OLINDA experience.
Topics: Female; Humans; Lutetium; Male; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Samarium; Zirconium | 2021 |